Quintessence debuts first ‘living’ artificial cell for CGT bio-separation
The technology is designed to simplify the bio-separation process while reducing manufacturing costs.
Calls for change as access to cell and gene therapies in the Netherlands falls short
Excalipoint debuts with $68.7m to progress TCE pipeline
GSK prepared for potential expansion of meningitis vaccine schedule amid UK outbreak
Navigating the valley of death: a how-to from an investor’s perspective
FDA issues CRL to Aldeyra’s reproxalap drug application
Analysis
View More
Themes
View MoreCinnaGen Enters EU Market with EMA Approval for Zandoriah®
CinnaGen today announced that the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Zandoriah® (teriparatide),…
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential
First responders see AI and other advanced tech as essential
What does the EU Data Act mean for businesses?